Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Share News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.80
Bid: 3.70
Ask: 3.90
Change: 0.10 (2.70%)
Spread: 0.20 (5.405%)
Open: 3.70
High: 3.80
Low: 3.70
Prev. Close: 3.70
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Mining stocks weigh on blue-chip index

Mon, 06th Mar 2023 12:16

(Alliance News) - Stock prices in London were largely lower at midday on Monday, with the FTSE 100 trading in the red, weighed down by poor performances by mining stocks.

The FTSE 100 index was down 37.28 points, or 0.5%, at 7,909.83, while the FTSE 250 was up points 30.01 points, or 0.2%, at 19,955.78. The AIM All-Share was down 2.34 points, or 0.3%, at 862.63.

The Cboe UK 100 was down 0.5% at 791.60, the Cboe UK 250 was flat at 17,495.79, and the Cboe Small Companies was down 0.5% at 13,876.58.

Sterling was slightly stronger at midday on Monday, despite unexpected positive news for the UK construction sector.

Construction activity picked up in the UK during February, as a rebound in commercial work offset a continued decline in housebuilding.

The S&P Global/CIPS UK construction purchasing managers' index rose to 54.6 points in February, from 48.4 in January.

Crossing over the 50-point no-change mark, it shows the sector saw a strong expansion in activity during the month. The reading was the highest since May last year, and well ahead of market consensus of 48.5, as cited by FXStreet.

The pound was quoted at USD1.2006 at midday on Monday in London, higher compared to USD1.1979 at the close on Friday.

In London, miners were amongst the worst blue-chip performers at midday, with Anglo American, Glencore, and Fresnillo falling 4.2%, 3.0%, and 2.1%, respectively. This is a reversal of last week, when a 1.2% five-day rise for the FTSE 100 was largely thanks to the same mining stocks.

On Monday, the miners were hit by a prediction by Chinese Premier Li Keqiang that the Chinese economy will grow by "around 5%" this year. This is down from last year's growth target of 5.5%.

Susannah Streeter, head of money and markets at Hargreaves Lansdown, said this year's target was not as high as had been hoped, particularly given the recent resurgence in factory activity and business confidence following the lifting of Covid restrictions.

"This will nudge down hopes that China could provide the extra steam to offset declines in other major economies, prompted by efforts to rein in rampant inflation," she said.

Not just a powerhouse of the global economy, China is a major buyer of commodities, so the outlook for demand now looks gloomier than expected.

Brent oil was quoted at USD84.54 a barrel at midday in London on Monday, down from USD85.34 late Friday. Gold was quoted at USD1,848.67 an ounce, slightly higher against USD1,845.56.

In the FTSE 250, Aston Martin jumped 15% as Jefferies raised the target price for the stock to 160p from 120p.

Last Wednesday, the luxury carmaker hailed its "strongest order book in many years" and closed off 2022 with a good final quarter, setting off a series of price target hikes by analysts.

Clarkson was up 5.5% after it reported a "record" performance in 2022, with revenue and profit both rising by double-digit percentages, and it raised its payout for the 20th year in a row.

The integrated shipping services provider said revenue jumped by 36% to GBP603.8 million from GBP443.3 million, driven mainly by the Broking division, as pretax profit increased by 45% to GBP100.1 million from GBP69.1 million.

Chief Executive Officer Andi Case said it was a "record year" for Clarksons and the company looked ahead to 2023 with confidence.

Elsewhere in London, Foxtons climbed 4.5% after it said it bought Atkinson McLeod for GBP7.4 million, confirming a report by Sky News on Sunday.

Atkinson McLeod is an estate agent operating in central and east London with four branches and increases Foxtons' exposure to the lettings market. Foxtons said the acquisition is expected to be accretive to earnings this year.

Meanwhile, James Fisher & Sons dropped 4.2%. The marine services provider said it sold its loss-making nuclear services business, James Fisher Nuclear, and its associated properties, and will take an impairment as a result.

James Fisher will receive the nominal sum of GBP3 for the business. It will impair the value of goodwill and tangible fixed assets of JFN in its annual results for 2022, in which the business will be shown as a discontinued operation.

In 2021, the division recorded a pretax loss of GBP100,000 on third-party revenue of GBP51.7 million.

On AIM, Fusion Antibodies plunged 32% after it said it expects annual revenue to be significantly below expectations as a result of continued uncertainty in the timings of orders.

Revenue in the financial year ending March 31 is now expected at no less than GBP2.8 million, "significantly" below current market expectations.

In European equities on Monday, the CAC 40 in Paris and the DAX 40 in Frankfurt were both up 0.3%.

The eurozone's construction sector contracted further in February, but at a slower pace than in January. The eurozone's construction PMI rose to 47.6 points in February from 46.1 in January.

In addition, retail sales in the eurozone unexpectedly fell year-on-year in January. Compared to January 2022, retail sales were 2.3% lower.

The decline slowed slightly from the annual fall of 2.8% seen in December. However, the result was well behind market consensus, which had expected growth of 1.9%.

The euro stood at USD1.0633, higher against USD1.0601. Against the yen, the dollar was trading at JPY136.11, lower compared to JPY136.21.

US Federal Reserve Chair Jerome Powell will give his semi-annual report on monetary policy to Congress on Tuesday and Wednesday. Ricardo Evangelista said this could create scope for dollar losses, should the central bank head present a "less hawkish tone than some of his peers have done recently".

CMC Market's Michael Hewson said that it was unlikely that Powell will give too many clues "given how close to the next meeting we are", instead suggesting that the "main takeaway" is likely to be data dependence.

The next Federal Open Market Committee meeting is on March 21 and 22.

"However, don't be surprised if markets pore over every single nuance just so that they can reinforce their own particular mindset," Hewson added.

Stocks in New York were called flat. The Dow Jones Industrial Average and the S&P 500 index were seen marginally lower, while the Nasdaq Composite was pointed marginally higher.

Still to come on Monday's economic calendar, US factory orders are published at 1500 GMT.

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
6 Mar 2023 10:52

Fusion Antibodies drops as annual revenue seen significantly lower

(Alliance News) - Fusion Antibodies PLC on Monday said it expects annual revenue to be significantly below expectations as a result of continued uncertainty in the timings of orders.

Read more
6 Mar 2023 10:48

AIM WINNERS & LOSERS: Amur to pay dividends after disposal completion

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
6 Mar 2023 09:04

LONDON MARKET OPEN: Sluggish open ahead of US Fed testimony this week

(Alliance News) - London's equities got off to a slow start on Monday, lagging behind more positive trading in Europe and Friday's rally on Wall Street.

Read more
9 Feb 2023 11:43

Fusion Antibodies launches first commercial service from OptiMAL

(Alliance News) - Fusion Antibodies PLC on Thursday celebrated the launch of a new commercial service from its research and development programme, designed to address mammalian cell surface expression.

Read more
5 Dec 2022 16:28

Fusion Antibodies confident after 'challenging' first half

(Sharecast News) - Contract research organisation Fusion Antibodies reported first-half revenues of £1.9m on Monday, down from £2.4m year-on-year.

Read more
5 Dec 2022 11:40

Fusion Antibodies half-year loss doubles amid investment delays

(Alliance News) - Fusion Antibodies PLC on Monday said its loss has widened and revenue is down, after the first half of the financial year proved a "challenging period".

Read more
28 Nov 2022 15:47

UK earnings, trading statements calendar - next 7 days

Tuesday 29 November 
ActiveOps PLCHalf Year Results
Altitude Group PLCHalf Year Results
Amaroq Minerals LtdQ3 Results
Atrato Onsite Energy PLCFull Year Results
Cordiant Digital Infrastructure LtdHalf Year Results
easyJet PLCFull Year Results
First Property Group PLCHalf Year Results
Focusrite PLCFull Year Results
Guanajuato Silver Co LtdQ3 Results
GB Group PLCHalf Year Results
Greencore Group PLCFull Year Results
Record PLCHalf Year Results
Renew Holdings PLCFull Year Results
Shaftesbury PLCFull Year Results
Shearwater Group PLCHalf Year Results
Supreme PLCHalf Year Results
Topps Tiles PLCFull Year Results
Treatt PLCFull Year Results
Victoria PLCHalf Year Results
VP PLCHalf Year Results
Wise PLCTrading Statement
Wednesday 30 November 
Benchmark Holdings PLCFull Year Results
Carclo PLCHalf Year Results
D4T4 Solutions PLCHalf Year Results
Future PLCFull Year Results
IG Design Group PLCHalf Year Results
Impax Asset Management Group PLCFull Year Results
LendInvest PLCHalf Year Results
Loungers PLCHalf Year Results
Mulberry Group PLCHalf Year Results
Ondo InsurTech PLCHalf Year Results
Pennon Group PLCHalf Year Results
Renalytix PLCQ1 Results
Thursday 1 December 
AJ Bell PLCFull Year Results
Auction Technology Group PLCFull Year Results
Creightons PLCHalf Year Results
DSW Capital PLCHalf Year Results
Duke Royalty LtdHalf Year Results
Foresight Group Holdings LtdHalf Year Results
James Latham PLCHalf Year Results
Peel Hunt LtdHalf Year Results
Residential Secure Income PLCFull Year Results
Friday 2 December 
Industrials REIT LtdHalf Year Results
Mind Gym PLCHalf Year Results
Premier Miton Group PLCFull Year Results
Monday 5 December 
Fusion Antibodies PLCHalf Year Results
Induction Healthcare Group PLCHalf Year Results
Tharisa PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
16 Sep 2022 15:55

UK shareholder meetings calendar - next 7 days

Monday 19 September 
Carr's Group PLCGM re Agricultural Supplies division sale
Tuesday 20 September 
AdEPT Technology Group PLCAGM
Appreciate Group PLCAGM
Cake Box Holdings PLCAGM
DP Eurasia NVEGM appointment of independent non-executive director
DSW Capital PLCAGM
FIH Group PLCAGM
Global Ports Holding PLCAGM
Gore Street Energy Storage Fund PLCAGM
Ilika PLCAGM
Manolete Partners PLCAGM
Moonpig Group PLCAGM
ProCook Group PLCAGM
Quiz PLCAGM
Shearwater Group PLCAGM
SulNOx Group PLCAGM
Utilico Emerging Markets Trust PLCAGM
Zoo Digital Group PLCAGM
Wednesday 21 September 
Games Workshop Group PLCAGM
Hipgnosis Songs Fund LtdAGM
IG Group Holdings PLCAGM
India Capital Growth Fund LtdAGM
Merit Group PLCAGM
Schroder Real Estate Investment Trust LtdAGM
SDI Group PLCAGM
Seraphine Group PLCAGM
Tintra PLCAGM
Thursday 22 September 
Begbies Traynor Group PLCAGM
Ecofin Global Utilities & Infrastructure Trust PLCGM pre-emption rights
IG Design Group PLCAGM
Liontrust Asset Management PLCAGM
Oberon Investments Group PLCAGM
Odyssean Investment Trust PLCAGM
Rockwood Strategic PLCGM trading to the premium segment
Trakm8 Holdings PLCAGM
Worsley Investors LtdAGM
Friday 23 September 
Accsys Technologies PLCAGM
Biffa PLCAGM
Bradda Head Lithium LtdAGM
Fusion Antibodies PLCAGM
In The Style Group PLCAGM
Safestay PLCAGM
Wise PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
23 Aug 2022 09:42

Fusion Antibodies sees revenue growth on transient expression service

(Alliance News) - Fusion Antibodies PLC on Tuesday said it achieved full-year revenue ahead of expectations, due to its transient expression service.

Read more
9 Aug 2022 17:11

IN BRIEF: Fusion Antibodies shares rise on patent application

Fusion Antibodies PLC - Belfast-based antibody developer - Submits patent application for its bispecific designs for antigen display. The designs include an antigen part, and a "reporter" part, called a "bispecific". Believes the reporter part will increase the rate of success in the identification of highly potent antibodies from its range of Antibody Discovery technologies.

Read more
28 Jul 2022 16:14

EXECUTIVE CHANGES: Cohort co-founder out; Nuformix co-founder back

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Thursday and not separately reported by Alliance News:

Read more
6 May 2022 12:52

Fusion Antibodies reports strong full-year revenue growth

(Sharecast News) - Preclinical antibody discovery and supply company Fusion Antibodies reported 14% growth in revenue in a trading update on Friday, to £4.8m.

Read more
6 May 2022 11:29

Fusion Antibodies annual revenue grows despite challenges

(Alliance News) - Fusion Antibodies PLC on Friday said it expects to post double-digit growth in revenue, leading to strong expectations for the current period.

Read more
21 Feb 2022 18:12

TRADING UPDATES: Panther Securities wins lease; NightCap opens new bar

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
10 Feb 2022 14:47

IN BRIEF: Fusion Antibodies sees no reason for share price fall

IN BRIEF: Fusion Antibodies sees no reason for share price fall

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.